Catalyst Wire Dossier Catalyst Wire Dossier

Asparaginase encapsulated in erythrocytes

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Asparaginase encapsulated in erythrocytes, covering 2024-03-15 to 2024-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase [Phase 2]

See pricing